Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ad-inserter domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the digital-newspaper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6131
Eli Lilly seeks FDA approval for weight loss drug tirzepatide » ZEE TECHNICAL Eli Lilly seeks FDA approval for weight loss drug tirzepatide » ZEE TECHNICAL

Eli Lilly seeks FDA approval for weight loss drug tirzepatide

0427 en battistew 1922499

[ad_1]

Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News


Watch CBS News



Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


[ad_2]

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *